Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma

BACKGROUND: Optimal management for recurrent IDH-mutant glioma after radiation therapy (RT) is not well-defined. This study assesses practice patterns for managing recurrent IDH-mutant astrocytoma (Astro) and 1p/19q codeleted oligodendroglioma (Oligo) after RT and surveys their clinical outcomes aft...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurooncol Adv
Main Authors: Ma, Sirui, Rudra, Soumon, Campian, Jian L, Chheda, Milan G, Johanns, Tanner M, Ansstas, George, Abraham, Christopher D, Chicoine, Michael R, Leuthardt, Eric C, Dowling, Joshua L, Dunn, Gavin P, Kim, Albert H, Huang, Jiayi
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2021
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8324173/
https://ncbi.nlm.nih.gov/pubmed/34345818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab081
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados